Disease Characteristics of IR-CAD: a Case-control Study

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

November 2, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Coronary Artery DiseaseCoronary Artery StenosisCoronary Artery RestenosisCoronary Artery Disease ProgressionInflammationInflammatory DiseaseInflammation Vascular
Interventions
DIAGNOSTIC_TEST

Protocol-defined Examinations

Lab tests (blood and urine and stool routine tests, hepatic and renal and thyroid function tests, tests for metabolic markers, tests for cardiac biomarkers, thrombosis-related tests, rheumatology tests, tests for inflammation markers), electrocardiography, echocardiography, Birmingham Vasculitis Activity Score (BVAS-3), 6-minute walk test, 1-minute squat test, vascular ultrasound, fibroblast activation protein inhibitor (FAPI) positron emission tomography/computed tomography (PET/CT), coronary angiography, optical coherence tomography (OCT), tests for exploratory biomarkers.

Trial Locations (1)

100730

RECRUITING

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER